[SCHEDULE 13D/A] Cadeler A/S SEC Filing
Rhea-AI Filing Summary
BW Altor Pte. Ltd. reports beneficial ownership of 78,495,522 ordinary shares of Cadeler A/S, equal to approximately 22.4% of the outstanding share capital based on a 350,479,238 share base. The filing amends prior Schedule 13D disclosures and confirms the working capital used for the purchases came from an equity injection by Mr. Sohmen-Pao using his personal funds. Recent transactions disclosed include purchases of 2,239,501 shares on September 10, 2025 at $52.00 and 1,442,210 shares on September 30, 2025 at a weighted average of $49.9463. The Reporting Person states sole voting and dispositive power over the shares and otherwise affirms prior Schedule 13D information remains in effect.
Positive
- 78,495,522 shares beneficially owned (approx. 22.4%)
- Reporting Person asserts sole voting and sole dispositive power over the shares
- Working capital came from an equity injection by Mr. Sohmen-Pao (personal funds)
- Recent purchases disclosed: 2,239,501 shares on 10-Sep-2025 at $52.00 and 1,442,210 shares on 30-Sep-2025 at weighted average $49.9463
Negative
- None.
Insights
TL;DR: BW Altor now holds a material 22.4% stake in Cadeler with sole voting control.
The Schedule 13D/A shows 78,495,522 shares owned, representing approximately 22.4% of Cadeler's outstanding ordinary shares based on the issuer's reported share count. The Reporting Person discloses sole voting and dispositive power, which indicates concentrated control over this position.
The filing also identifies the source of funds as a personal equity injection by Mr. Sohmen-Pao and lists recent purchases on September 10, 2025 and September 30, 2025 totaling 3,681,711 shares at prices around $49.95–$52.00. This is material to investors because it documents both the size of the stake and the funding source behind the accumulation.